CAPRCapricor Therapeutics, Inc.

$30.40

$3.8452 weeks$35.34

Price

$30.40+229%1Y

1M+3.5%1Y+229%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Average

5/10

Value34

Quality47

Momentum83

Growth-

Strongest Momentum, weakest Value · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

Capricor Therapeutics, Inc. is a biotechnology company focused on the development and potential commercialization of cell and exosome-based therapeutics for the treatment of Duchenne muscular dystrophy (“DMD”), a rare genetic disorder characterized by progressive muscle degeneration and premature death, as well as other diseases with significant unmet medical need.

In the company’s own words · 10-K filed Mar 17, 2026 · SEC EDGAR

P/E (TTM)-

Market Cap$1.64B

1Y Return+229%

5Y Return+501%

For the full year FY2025, revenue was $0 (−100% year on year) and net income −$105M.